DaVita (DVA) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
DaVita HealthCare Partners Inc. 2nd Quarter 2016 Results
August 8, 2016 4:01 PM EDTDENVER, Aug. 8, 2016 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2016. Net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016 was $53 million, or $0.26 per share, which included goodwill impairment charges related to certain HCP reporting units, a gain on the partial sale of HCP's Tandigm Health (Tandigm) ownership interest and a loss on the sale of our HCP Arizona business as discussed below. Adjusted net income attributable to DaVita HealthCare Partners Inc. for the three months ended June 30, 2016... More
